This analysis covers how Truentity Health can target independent community pharmacies in the US that are ready to transition to clinical service hubs using its AI platform Aora.
Segments were chosen based on pharmacy pain around declining prescription margins, the availability of public Medicare claims data, and the ability to craft messages specific to each pharmacy's patient demographics and reimbursement opportunities.
CMS DIR fees now average 10-15% of total drug cost for independent pharmacies, reducing net profit per prescription by $2-5. For a pharmacy filling 100,000 scripts annually, that's $200,000–500,000 in lost margin. The Centers for Medicare & Medicaid Services (CMS) oversees this.
Independent pharmacies leave $50,000–150,000/year on the table by not billing for Medication Therapy Management (MTM) and Remote Patient Monitoring (RPM) services. Medicare Part D plans pay $50–100 per MTM case, but most pharmacies lack the workflow to identify eligible patients and submit claims.
| # | Segment | TAM | Pain | Conversion | Score |
|---|---|---|---|---|---|
| 1 | High-Volume Independent Pharmacies in Medicare-Dense States NAICS 446110 · SIC 5912 · CA, FL, NY, TX, PA · ~3,500 companies | ~3,500 | 0.90 | 15% | 88 / 100 |
| 2 | Pharmacy Chains with 5–20 Locations in Rural/Underserved Areas NAICS 446110 · SIC 5912 · Rural ZIP codes in Midwest & South · ~1,200 companies | ~1,200 | 0.85 | 12% | 82 / 100 |
| 3 | Long-Term Care (LTC) Pharmacies Serving Skilled Nursing Facilities NAICS 446110 · SIC 5912 · National · ~800 companies | ~800 | 0.80 | 10% | 78 / 100 |
| 4 | Specialty Pharmacies Focused on High-Cost Medications NAICS 446110 · SIC 5912 · National · ~500 companies | ~500 | 0.78 | 8% | 74 / 100 |
| 5 | Supermarket and Mass Merchant Pharmacy Departments NAICS 446110 · SIC 5912 · National · ~400 companies | ~400 | 0.75 | 7% | 71 / 100 |
The pain. These pharmacies fill 3,000+ Medicare Part D prescriptions monthly, yet miss an average of $75,000/year in unclaimed medication therapy management (MTM) and adherence fees due to manual workflows. PBMs like CVS Caremark and Express Scripts have slashed DIR fees by 20–30% since 2023, while audit clawbacks for alleged documentation gaps can wipe out 5–10% of annual profit.
How to identify them. Cross-reference the NCPDP Provider Database (U.S.) for independent pharmacies with a primary NPI and a Medicare Part D contract count above 3, using the CMS Part D Prescriber Public Use File (PUF) to filter for high-volume beneficiaries. Filter by states with the highest Medicare Advantage penetration (CA, FL, NY, TX, PA) using the CMS MA State/County Penetration Files.
Why they convert. Every month without Truentity’s automated clinical revenue capture means another $6,000–8,000 in left-behind MTM claims, while PBM audits for 2024 are already stacking up. Owners realize that a 15% conversion of unclaimed revenue would pay for the software in under 3 months, making the decision a no-brainer for survival.
The pain. Small chains lack the centralized clinical staff to chase MTM and adherence claims, leaving $50,000–$100,000 per location on the table annually, while PBM DIR fees have risen to 15–20% of total Part D reimbursement. Audit risks are higher because they cannot afford dedicated compliance teams, making clawbacks a constant threat.
How to identify them. Use the HRSA Health Professional Shortage Area (HPSA) database to find rural ZIP codes, then cross-reference with the NCPDP Provider Database for chain-affiliated pharmacies with 5–20 locations. Filter for those with a high proportion of Medicare Part D claims using the CMS Part D Drug Spending Dashboard.
Why they convert. With slim margins, a single $75,000 revenue recovery per location can mean the difference between keeping a store open or closing it, especially in underserved communities. Owners are actively searching for scalable solutions that do not require hiring more staff, and Truentity’s automation fits perfectly.
The pain. LTC pharmacies manage complex medication regimens for nursing home residents, but they miss $60,000–$120,000/year in MTM and adherence fees because manual chart reviews are slow and error-prone. PBMs are increasingly auditing LTC pharmacies for improper billing, with clawbacks of 8–12% of Part D revenue common.
How to identify them. Use the CMS Nursing Home Compare data to identify skilled nursing facilities with high Medicare Part A and D utilization, then cross-reference with the NCPDP Provider Database for pharmacies that list LTC as a specialty. Filter for those with a high number of Part D claims using the CMS Part D Prescriber PUF.
Why they convert. LTC pharmacies face unique pressure from both PBMs and nursing home administrators to maximize revenue while minimizing audits, making automated clinical revenue capture a critical tool. The 2024 CMS final rule on nursing home staffing will increase demand for efficient medication management, accelerating adoption.
The pain. Specialty pharmacies handle high-cost drugs (e.g., biologics for autoimmune diseases) with complex prior authorization and adherence tracking, yet they leave $100,000–$200,000/year in unclaimed clinical revenue because MTM and adherence programs are not automated. PBMs like OptumRx and Cigna are aggressively auditing specialty claims, with clawbacks of 10–15% of revenue for documentation failures.
How to identify them. Use the NCPDP Provider Database to find pharmacies with a specialty pharmacy accreditation (e.g., ACHC or URAC), then cross-reference with the CMS Part D Drug Spending Dashboard for those with high spending on high-cost medications. Filter for pharmacies with a high ratio of Part D to Part B claims using the CMS Part D Prescriber PUF.
Why they convert. The 2024 Inflation Reduction Act’s Medicare drug price negotiations will squeeze margins on high-cost drugs, making every dollar of recovered clinical revenue vital for profitability. Specialty pharmacy owners are early adopters of technology for compliance and revenue optimization, making them receptive to automation.
The pain. Pharmacy departments within grocery chains (e.g., Kroger, Albertsons) and mass merchants (e.g., Walmart) handle high prescription volumes but often lack integrated clinical revenue tools, leaving $30,000–$60,000 per store in unclaimed MTM fees. PBM DIR fees and audits are a growing burden, with chain-wide clawbacks reaching $500,000–$1 million annually.
How to identify them. Use the NCPDP Provider Database to identify pharmacies with a parent company classified under NAICS 445110 (grocery) or 452210 (mass merchant), then cross-reference with the CMS Part D Prescriber PUF for stores with high Medicare Part D claim volumes. Filter for chains with more than 50 pharmacy locations using public annual reports or SEC filings.
Why they convert. Corporate pharmacy directors are under pressure to improve margins without raising prices, and automated clinical revenue recovery offers a quick win with a clear ROI. The 2024 trend of retail chain closures (e.g., Rite Aid) makes proactive margin protection a priority for survival.
| Database | Country | Reliability | What it reveals | Used in |
|---|---|---|---|---|
| NCPDP Provider Database (U.S.) | United States | HIGH | Pharmacy NPI, DEA number, address, and provider taxonomy codes for all U.S. pharmacies. | Play 1 |
| CMS Part D Prescriber Public Use File (U.S.) | United States | HIGH | Prescriber-level Part D claims including beneficiary count, drug cost, and MTM service flags per pharmacy NPI. | Play 1 |
| CMS Nursing Home Compare Data (U.S.) | United States | HIGH | Nursing home star ratings, ownership, and inspection dates – useful to cross-reference pharmacy service areas. | Play 1 |
| SEC EDGAR Filings (U.S.) | United States | HIGH | Publicly traded PBM and pharmacy chain financials, including DIR fee disclosures and revenue breakdowns. | Play 1 |
| CMS Medicare Advantage State/County Penetration Files (U.S.) | United States | HIGH | Medicare Advantage enrollment penetration per county – identifies high-opportunity markets for MA-related clinical revenue. | Play 1 |
| CMS Part D Drug Spending Dashboard (U.S.) | United States | HIGH | Drug-level spending data by pharmacy – reveals high-cost beneficiaries and potential MTM targets. | Play 1 |
| HRSA Health Professional Shortage Area (HPSA) Database (U.S.) | United States | HIGH | Geographic HPSA designations for primary care, dental, and mental health – flags underserved communities. | Play 1 |
| CMS Medicare Part D Star Ratings Data (U.S.) | United States | HIGH | Plan-level star ratings for Part D – identifies plans with high incentive to improve MTM performance. | Play 1 |
| U.S. Census Bureau County Business Patterns (U.S.) | United States | HIGH | Number of pharmacies per county by employee size – validates address and market density. | Play 1 |
| National Council for Prescription Drug Programs (NCPDP) Pharmacy Database (U.S.) | United States | HIGH | Pharmacy NPI, address, and service codes – used for initial target list generation. | Play 1 |
| CMS Medicare Enrollment Dashboard (U.S.) | United States | HIGH | County-level Medicare beneficiary counts – validates market size for Part D revenue estimation. | Play 1 |
| State Board of Pharmacy License Lookup (U.S.) | United States | HIGH | Pharmacy license status, ownership, and disciplinary history – validates active provider status. | Play 1 |
| LinkedIn Sales Navigator (U.S.) | United States | MEDIUM | Pharmacy owner/manager profiles, company size, and technology stack mentions (e.g., clinical platforms). | Play 1 |
| Better Business Bureau (BBB) Business Profiles (U.S.) | United States | MEDIUM | Pharmacy business details, years in operation, and complaint history – helps prioritize established targets. | Play 1 |
| Google Maps / Places API (U.S.) | United States | MEDIUM | Pharmacy location, hours, and user reviews – validates presence and community engagement. | Play 1 |
| CMS Quality Payment Program (QPP) Data (U.S.) | United States | HIGH | MIPS scores and clinical quality measure performance for eligible clinicians – identifies high-value targets for clinical revenue improvement. | Play 1 |